Fortive Corporation reported its second-quarter financial results, topping analyst expectations on both revenue and earnings per share while raising its full-year guidance according to Tradingview. The company posted second-quarter revenue of $1.10 billion, edging past analyst estimates of $1.07 billion and marking a 7.9% increase year-on-year.
Fortive Exceeds Second-Quarter Revenue Estimates and Raises Guidance
Adjusted earnings per share reached $0.74, beating the analyst consensus of $0.71. Driven by the quarterly performance, management raised its full-year adjusted EPS guidance to a midpoint of $3, representing a 1.7% increase. Additional data provided in reports from Sharewise noted a broader full-year adjusted EPS outlook range of $2.95 to $3.05, alongside reported revenue of roughly $4.35 billion and core revenue growth forecasted at about 4%, up from a prior estimate of 2% to 3%.
Segment Performance and Strategic Growth Drivers
President and CEO Olumide Soroye attributed the results to ongoing execution under the Fortive Accelerated
strategy, which prioritizes innovation, commercial investments, recurring customer value, and disciplined capital allocation. Soroye noted that the period marked the company’s fourth consecutive quarter of double-digit adjusted EPS growth.
Core revenue grew 6.7%, while adjusted EBITDA rose 12% to $323.1 million, beating analyst projections of $316.1 million and achieving a 29.5% margin. Operating margins rose to 19.1%, compared to 16.7% in the same period last year.
Performance across key segments and product lines included: – Intelligent Operating Solutions: Reported revenue grew approximately 9% and 7.4% organically, supported by strong demand for Fluke’s data-center products and new product introductions. – Advanced Healthcare Solutions: Generated nearly $340 million in revenue, up 6% year-on-year and 5.3% on a core basis, bolstered by healthcare consumables, services, and software sales across North America, Latin America, and Asia-Pacific. – Acquisitions: The company acquired a majority stake in UV Smart to expand its healthcare disinfection portfolio.
Regional Dynamics and Margin Pressures
North America remained the strongest geographical region for the firm. Growth in the Asia-Pacific and Latin America regions helped offset a modest revenue decline in Europe, the Middle East, and Africa. Management attributed the weakness in EMEA to geopolitical tensions, economic softness, and deferred purchases from a small number of channel customers, though point-of-sale trends in the area reached their highest level in six quarters.
Despite consolidated adjusted EBITDA increasing to $323.1 million and adjusted EBITDA margins expanding by about 110 basis points to 29.5%, executives addressed certain headwinds. CFO Mark Okerstrom explained that product mix—specifically growth in lower-margin lines—alongside strategic growth investments and tax rates expected in the mid-teens for the year, exerted pressure on gross margins. Okerstrom projected that margin pressures would ease in the fourth quarter as seasonal dynamics normalize.
Cash Flow and Capital Allocation
Fortive generated approximately $270 million in quarterly free cash flow, with trailing 12-month free cash flow exceeding $1 billion and conversion on net income staying well north of 100%.
During the quarter, the company repurchased about $200 million of its shares. This latest round of buybacks brought total share repurchases since the launch of the “New Fortive” to nearly $2 billion.
Keep reading